ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

DRIO vs PLRZ // RETURN ON INVESTED CAPITAL (ROIC)

DarioHealth Corp. (NASDAQ) VS. Polyrizon Ltd. (NASDAQ) • 15-METRIC TALLY: DRIO 2 — PLRZ 2
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: PLRZ
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DRIO VS. PLRZ) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC DRIO PLRZ SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 56.60% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) ACTIVE -35.00% -25.10% -9.90 PLRZ /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — -20.74% — TIE /fcf-yield <GO>
Operating Margin -60.00% — — TIE /operating-margins <GO>
Net Profit Margin -60.00% — — TIE /net-margins <GO>
Revenue Growth (YoY) — — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 5/9 1/9 +4.00 DRIO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 27.3 56.5 -29.20 PLRZ /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $29.4M $26.1M $3.3M DRIO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR DRIO REV PLRZ REV DRIO GROSS % PLRZ GROSS % DRIO FCF PLRZ FCF
FY 2025 $22.4M $17.5M 56.6% — -$26.1M -$4.5M
FY 2024 $27.0M $3.6M 49.1% — -$38.7M -$1.1M
FY 2023 $157.3M $1.8M — — -$30.4M -$537.0K
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DRIO // BETA —
PLRZ // BETA —